$238 Million is the total value of KNOTT DAVID M's 157 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 30.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Incorporated | $35,141,000 | -12.8% | 353,041 | 0.0% | 14.76% | -13.2% | |
| SRCL | Buy | Stericycle, Inc. | $15,996,000 | +24.5% | 314,083 | +16.7% | 6.72% | +24.0% |
| UPLD | Upland Software, Inc. | $15,269,000 | -23.4% | 438,000 | 0.0% | 6.42% | -23.7% | |
| FTAI | Buy | Fortress Trans & Infrastructure Inv. LLC | $13,461,000 | +2.1% | 888,509 | +1.7% | 5.66% | +1.6% |
| APO | New | Apollo Global Management, Inc. | $12,205,000 | – | 322,708 | +100.0% | 5.13% | – |
| MPLX | Buy | MPLX LP | $10,267,000 | -3.2% | 366,558 | +11.2% | 4.31% | -3.6% |
| GOOG | Alphabet Inc-Cl C | $9,630,000 | +12.8% | 7,900 | 0.0% | 4.05% | +12.3% | |
| LKQ | LKQ Corporation | $9,435,000 | +18.2% | 300,000 | 0.0% | 3.96% | +17.7% | |
| FSK | New | FS KKR Capital Corp. | $8,902,000 | – | 1,527,000 | +100.0% | 3.74% | – |
| IGT | International Gaming Technologies | $8,633,000 | +9.6% | 607,500 | 0.0% | 3.63% | +9.1% | |
| TSG | Buy | The Stars Group Inc. | $8,176,000 | +1.7% | 545,800 | +15.9% | 3.44% | +1.3% |
| CLMT | Buy | Calumet Specialty Products Partners, LP | $7,353,000 | -9.0% | 2,020,000 | +4.8% | 3.09% | -9.3% |
| MIC | Macquarie Infrastructure Corporation | $6,942,000 | -2.7% | 175,900 | 0.0% | 2.92% | -3.1% | |
| PFE | Sell | Pfizer Inc. | $4,739,000 | -24.6% | 131,900 | -9.0% | 1.99% | -24.8% |
| DAL | Delta Air Lines, Inc. | $3,312,000 | +1.5% | 57,500 | 0.0% | 1.39% | +1.1% | |
| FNMAT | Buy | Fannie Mae 8.25 percent Series T | $3,043,000 | +205.5% | 234,236 | +175.6% | 1.28% | +204.3% |
| JPM | JP Morgan Chase | $2,713,000 | +5.3% | 23,050 | 0.0% | 1.14% | +4.9% | |
| CHCT | Community Healthcare Trust Incorporated | $2,673,000 | +13.0% | 60,000 | 0.0% | 1.12% | +12.5% | |
| ABBV | Buy | AbbVie Inc. | $2,496,000 | +208.9% | 32,953 | +196.9% | 1.05% | +207.6% |
| EIGR | Buy | Eiger BioPharmaceuticals, Inc. | $2,403,000 | +4.5% | 234,448 | +8.1% | 1.01% | +4.1% |
| AOBC | American Outdoor Brands Corporation | $2,282,000 | -35.1% | 390,000 | 0.0% | 0.96% | -35.3% | |
| BDSI | Buy | BioDelivery Sciences International, Inc. | $2,179,000 | +3.5% | 517,507 | +14.3% | 0.92% | +3.0% |
| FREJP | New | Freddie Mac 5.3 percent | $2,135,000 | – | 100,000 | +100.0% | 0.90% | – |
| RDUS | Sell | Radius Health Inc. | $1,887,000 | +0.3% | 73,269 | -5.2% | 0.79% | -0.1% |
| EPRT | Buy | Essential Properties Realty Trust, Inc. | $1,833,000 | +128.6% | 80,000 | +100.0% | 0.77% | +127.8% |
| FMCKJ | Buy | Freddie Mac 8.375 percent Series Z | $1,826,000 | +175.8% | 139,500 | +161.5% | 0.77% | +174.9% |
| HZNP | New | Horizon Therapeutics Public Ltd. Company | $1,753,000 | – | 64,364 | +100.0% | 0.74% | – |
| XENE | Buy | Xenon Pharmaceuticals Inc. | $1,688,000 | -4.6% | 187,311 | +4.4% | 0.71% | -5.0% |
| CELG | Celgene Corporation | $1,574,000 | +7.4% | 15,847 | 0.0% | 0.66% | +7.0% | |
| BLU | New | Bellus Health Inc. | $1,559,000 | – | 242,611 | +100.0% | 0.66% | – |
| BMY | Buy | Bristol-Myers Squibb Company | $1,515,000 | +23.4% | 29,868 | +10.3% | 0.64% | +22.8% |
| VKTX | Viking Therapeutics, Inc. | $1,501,000 | -17.1% | 218,102 | 0.0% | 0.63% | -17.4% | |
| AB | AllianceBernstein Holdings PL Unit Ltd | $1,482,000 | -1.3% | 50,500 | 0.0% | 0.62% | -1.6% | |
| MIK | Sell | The Michaels Companies, Inc. | $1,469,000 | -43.7% | 150,000 | -50.0% | 0.62% | -44.0% |
| CHRS | Buy | Coherus Biosciences, Inc. | $1,284,000 | -6.9% | 63,387 | +1.6% | 0.54% | -7.4% |
| AIMT | Sell | Aimmune Therapeutics, Inc. | $1,173,000 | -1.9% | 55,990 | -2.6% | 0.49% | -2.4% |
| FOMX | Buy | Foamix Pharmaceuticals Ltd. | $1,128,000 | +27.7% | 371,146 | +0.0% | 0.47% | +27.4% |
| STML | Buy | Stemline Therapeutics, Inc. | $1,124,000 | -27.1% | 107,934 | +7.3% | 0.47% | -27.4% |
| VZ | Verizon Communications Inc. | $1,106,000 | +5.7% | 18,311 | 0.0% | 0.46% | +5.4% | |
| RHP | Ryman Hospitality Ppty Inc. | $1,015,000 | +1.0% | 12,400 | 0.0% | 0.43% | +0.5% | |
| FNMAL | New | Fannie Mae 4.75 percent Series M | $978,000 | – | 43,000 | +100.0% | 0.41% | – |
| JNJ | Johnson & Johnson | $942,000 | -7.1% | 7,280 | 0.0% | 0.40% | -7.5% | |
| GMREPRA | Global Medical REIT, Inc. Ser A Cum Pfd. | $930,000 | +1.3% | 35,000 | 0.0% | 0.39% | +1.0% | |
| DD | Dupont DE Nemours Inc. | $895,000 | -5.0% | 12,545 | 0.0% | 0.38% | -5.3% | |
| MDLZ | Mondelez Int'l Inc. | $879,000 | +2.6% | 15,900 | 0.0% | 0.37% | +1.9% | |
| XLRN | Buy | Acceleron Pharma, Inc. | $859,000 | +17.5% | 21,749 | +22.2% | 0.36% | +17.2% |
| CNQ | Sell | Canadian Natural Resources Inc. | $853,000 | -2.3% | 32,035 | -1.0% | 0.36% | -2.7% |
| KMB | Kimberly Clark Corporation | $852,000 | +6.5% | 6,000 | 0.0% | 0.36% | +6.2% | |
| T | AT&T Inc. | $835,000 | +13.0% | 22,050 | 0.0% | 0.35% | +12.5% | |
| CPRX | Sell | Catalyst Pharmaceuticals, Inc. | $804,000 | -39.0% | 151,415 | -55.9% | 0.34% | -39.2% |
| FNMAS | New | Fannie Mae 8.25 percent Series S | $801,000 | – | 60,000 | +100.0% | 0.34% | – |
| KO | Coca Cola | $730,000 | +7.0% | 13,400 | 0.0% | 0.31% | +6.6% | |
| ARNA | Sell | Arena Pharmaceuticals, Inc. | $659,000 | -38.7% | 14,391 | -21.5% | 0.28% | -38.9% |
| FMCKL | New | Freddie Mac 6.02 percent Series X | $651,000 | – | 53,811 | +100.0% | 0.27% | – |
| IBM | International Business Machines | $623,000 | +5.4% | 4,284 | 0.0% | 0.26% | +5.2% | |
| FNMAH | New | Fannie Mae Float Series P | $599,000 | – | 49,720 | +100.0% | 0.25% | – |
| DOW | Dow Inc. | $598,000 | -3.4% | 12,545 | 0.0% | 0.25% | -3.8% | |
| QTNT | Sell | Quotient Limited | $548,000 | -65.5% | 70,542 | -58.5% | 0.23% | -65.7% |
| WPC | WP Carey | $537,000 | +10.3% | 6,000 | 0.0% | 0.23% | +10.2% | |
| CHEKW | Check Cap Ltd. @7.50 Exp. 2/28/20 | $482,000 | 0.0% | 64,309 | 0.0% | 0.20% | -0.5% | |
| FMCKK | New | Freddie Mac 5 percent Series F | $473,000 | – | 21,590 | +100.0% | 0.20% | – |
| FMCKM | New | Freddie Mac 5.57 percent Series V | $445,000 | – | 39,739 | +100.0% | 0.19% | – |
| CBAY | Buy | CymaBay Therapeutics, Inc. | $413,000 | +175.3% | 80,889 | +285.2% | 0.17% | +176.2% |
| CDTX | Buy | Cidara Therapeutics, Inc. | $390,000 | +80.6% | 195,666 | +52.2% | 0.16% | +80.2% |
| CLBK | Columbia Financial, Inc. | $369,000 | +4.5% | 23,363 | 0.0% | 0.16% | +4.0% | |
| CTVA | Corteva Inc. | $351,000 | -5.4% | 12,545 | 0.0% | 0.15% | -5.8% | |
| DELL | Dell Technologies Inc. | $333,000 | +2.1% | 6,426 | 0.0% | 0.14% | +1.4% | |
| CAG | Conagra Brands | $307,000 | +15.8% | 10,000 | 0.0% | 0.13% | +15.2% | |
| ENFC | Entegra Financial Corporation | $308,000 | 0.0% | 10,250 | 0.0% | 0.13% | -0.8% | |
| AUPH | Sell | Aurinia Pharmaceuticals Inc. | $283,000 | -25.9% | 53,000 | -8.6% | 0.12% | -26.1% |
| KDMN | New | Kadmon Holdings, Inc. | $264,000 | – | 104,700 | +100.0% | 0.11% | – |
| ALIM | Buy | Alimera Sciences, Inc. | $259,000 | -34.6% | 458,120 | +3.1% | 0.11% | -34.7% |
| AAPL | Sell | Apple Inc. | $236,000 | -95.2% | 1,050 | -95.8% | 0.10% | -95.3% |
| FNMAM | New | Fannie Mae 5.81 percent Series H | $228,000 | – | 10,000 | +100.0% | 0.10% | – |
| WHLRD | Wheeler Real Estate Investment Trust, Inc. | $203,000 | -5.6% | 14,309 | 0.0% | 0.08% | -6.6% | |
| KRYS | Krystal Biotech, Inc. | $201,000 | -13.7% | 5,797 | 0.0% | 0.08% | -14.3% | |
| MSFT | Microsoft Corporation | $195,000 | +3.7% | 1,400 | 0.0% | 0.08% | +3.8% | |
| FNMAN | New | Fannie Mae 5.125 percent Series L | $193,000 | – | 8,680 | +100.0% | 0.08% | – |
| FSBW | FS Bancorp Inc. | $188,000 | +1.1% | 3,577 | 0.0% | 0.08% | +1.3% | |
| BLCM | Sell | Bellicum Pharmaceuticals | $177,000 | -59.3% | 168,203 | -34.2% | 0.07% | -59.6% |
| CSFL | Centerstate Banks Corp | $167,000 | +4.4% | 6,942 | 0.0% | 0.07% | +4.5% | |
| HRGG | Heritage NOLA Bancorp Inc. | $152,000 | -0.7% | 12,000 | 0.0% | 0.06% | -1.5% | |
| TTE | Sell | Total SA | $149,000 | -49.3% | 2,860 | -45.6% | 0.06% | -49.2% |
| VRCA | Sell | Verrica Pharmaceuticals, Inc. | $151,000 | +17.1% | 10,207 | -8.1% | 0.06% | +16.7% |
| GMED | Buy | Globus Medical, Inc. | $148,000 | +85.0% | 2,900 | +52.6% | 0.06% | +82.4% |
| LEGH | Legacy Housing Corporation | $146,000 | +30.4% | 9,000 | 0.0% | 0.06% | +29.8% | |
| KHC | Sell | The Kraft Heinz Company | $137,000 | -50.4% | 4,900 | -44.9% | 0.06% | -50.0% |
| ORIT | Oritani Financial Corp | $138,000 | +0.7% | 7,800 | 0.0% | 0.06% | 0.0% | |
| CFFN | Capitol Federal Financial Inc. | $135,000 | 0.0% | 9,800 | 0.0% | 0.06% | 0.0% | |
| OXY | New | Occidental Pete Corp | $133,000 | – | 2,973 | +100.0% | 0.06% | – |
| NVS | Sell | Novartis AG | $130,000 | -52.6% | 1,500 | -50.0% | 0.06% | -52.6% |
| CUZ | Cousins Properties | $126,000 | +4.1% | 3,357 | 0.0% | 0.05% | +3.9% | |
| FMCCP | New | Freddie Mac 6 percent Series P | $116,000 | – | 5,200 | +100.0% | 0.05% | – |
| MDT | Medtronics Inc. | $114,000 | +11.8% | 1,050 | 0.0% | 0.05% | +11.6% | |
| Merck & Co. Inc. | $109,000 | 0.0% | 1,300 | 0.0% | 0.05% | 0.0% | ||
| OFIX | Orthofix Medical Inc. | $106,000 | 0.0% | 2,000 | 0.0% | 0.04% | 0.0% | |
| FNB | FNB Corporation | $103,000 | -1.9% | 8,905 | 0.0% | 0.04% | -2.3% | |
| LXRX | Sell | Lexicon Pharmaceuticals, Inc. | $90,000 | -52.4% | 29,800 | -0.7% | 0.04% | -52.5% |
| NVLNF | Novelion Therapeutics, Inc. | $79,000 | -7.1% | 109,135 | 0.0% | 0.03% | -8.3% | |
| MEIP | MEI Pharma, Inc. | $65,000 | -32.3% | 38,590 | 0.0% | 0.03% | -32.5% | |
| New | Ascendis Pharma A/S | $63,000 | – | 656 | +100.0% | 0.03% | – | |
| GE | General Electric | $42,000 | -16.0% | 4,680 | 0.0% | 0.02% | -14.3% | |
| ALC | Alcon, Inc | $35,000 | -5.4% | 600 | 0.0% | 0.02% | -6.2% | |
| LLY | Eli Lilly Inc. | $34,000 | +3.0% | 300 | 0.0% | 0.01% | 0.0% | |
| CCXI | New | ChemoCentryx, Inc | $34,000 | – | 5,000 | +100.0% | 0.01% | – |
| SVC | New | Service Ppty Trust | $26,000 | – | 1,000 | +100.0% | 0.01% | – |
| BNS | Bank Nova Scotia Halifax | $23,000 | +4.5% | 400 | 0.0% | 0.01% | +11.1% | |
| PBCT | Peoples United Financial | $23,000 | -8.0% | 1,500 | 0.0% | 0.01% | -9.1% | |
| EXP | Eagle Materials Inc. | $21,000 | 0.0% | 228 | 0.0% | 0.01% | 0.0% | |
| CC | Sell | Chemours Co. | $18,000 | -43.8% | 1,160 | -14.7% | 0.01% | -38.5% |
| FNMFM | New | Fannie Mae 5.1 percent Series E | $11,000 | – | 500 | +100.0% | 0.01% | – |
| CLNS | Colony Northstar Inc. | $9,000 | +28.6% | 1,466 | 0.0% | 0.00% | +33.3% | |
| STWD | Starwood Ppty | $10,000 | +11.1% | 400 | 0.0% | 0.00% | 0.0% | |
| CHEK | Check Cap Ltd. | $4,000 | -20.0% | 2,224 | 0.0% | 0.00% | 0.0% | |
| AMLP | Alerian MLP | $5,000 | -16.7% | 600 | 0.0% | 0.00% | -33.3% | |
| SCU | New | Sculptor Cap Mgmt | $4,000 | – | 200 | +100.0% | 0.00% | – |
| RMR | RMR Group Inc. | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – | |
| Bellicum Pharmaceuticals @ 5 exp 11/19 | $1,000 | -98.0% | 100 | 0.0% | 0.00% | -100.0% | ||
| WAB | WABTEC | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – | |
| OZM | Exit | Och-Ziff Capital Management Group | $0 | – | -200 | -100.0% | -0.00% | – |
| VIVE | Exit | Viveve Medical, Inc. | $0 | – | -43,649 | -100.0% | -0.01% | – |
| F | Exit | Ford Motor Company | $0 | – | -5,000 | -100.0% | -0.02% | – |
| Exit | Ascendis Pharma A/S | $0 | – | -656 | -100.0% | -0.03% | – | |
| GM | Exit | General Motors | $0 | – | -5,000 | -100.0% | -0.08% | – |
| GILD | Exit | Gilead Sciences, Inc. | $0 | – | -3,500 | -100.0% | -0.10% | – |
| HPT | Exit | Hospitality Properties Trust | $0 | – | -25,000 | -100.0% | -0.26% | – |
| APC | Exit | Anadarko Petroleum Corporation | $0 | – | -15,960 | -100.0% | -0.48% | – |
| Exit | Intec Pharma Ltd. | $0 | – | -259,377 | -100.0% | -0.48% | – | |
| HZNP | Exit | Horizon Therapeutics Public Ltd. Company | $0 | – | -50,046 | -100.0% | -0.51% | – |
| HHC | Exit | The Howard Hughes Corporation | $0 | – | -13,000 | -100.0% | -0.68% | – |
| LOW | Exit | Lowe's Companies, Inc. | $0 | – | -45,000 | -100.0% | -1.92% | – |
| APO | Exit | Apollo Global Management, LLC | $0 | – | -322,708 | -100.0% | -4.67% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 34 | Q3 2021 | 52.6% |
| Pfizer Inc. | 34 | Q3 2021 | 17.4% |
| Capitol Federal S&L | 34 | Q3 2021 | 5.7% |
| JP Morgan Chase& Co. | 34 | Q3 2021 | 1.3% |
| Apple Inc. | 34 | Q3 2021 | 2.1% |
| Microsoft Corporation | 34 | Q3 2021 | 2.3% |
| AllianceBernstein Holdings PL Unit Ltd. | 34 | Q3 2021 | 0.9% |
| Johnson & Johnson | 34 | Q3 2021 | 0.6% |
| Mondelez Int'lt Inc. | 34 | Q3 2021 | 0.5% |
| Ryman Hospitality PPTYS Inc. | 34 | Q3 2021 | 0.4% |
View KNOTT DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | February 13, 2018 | 865,500 | 4.1% |
| Rand Logistics, Inc. | November 15, 2017 | 1,432,660 | 7.2% |
| Essex Rental Corp. | August 16, 2013 | 1,124,472 | 4.5% |
| Westway Group, Inc. | February 01, 2013 | ? | ? |
| FutureFuel Corp. | February 01, 2012 | 1,838,000 | 4.5% |
| COLUMBIA LABORATORIES INC | January 31, 2012 | ? | ? |
| Essex Rental Corp. | February 16, 2011 | 2,805,666 | 13.0% |
| Pet DRx CORPSold out | February 09, 2011 | 0 | 0.0% |
| China Ceramics Co., Ltd | October 14, 2010 | 1,350,000 | 10.3% |
| NABI BIOPHARMACEUTICALS | June 22, 2010 | 2,344,597 | 4.8% |
View KNOTT DAVID M's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-13 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-12 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-12 |
| 13F-HR | 2019-08-12 |
View KNOTT DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.